aer-271
Small moleculeexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 26, 2018 (NCT03804476)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Aquaporin-4INHIBITOR
AQP4 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05200728 | Phase 1 | Dec 2, 2021 | Capital Medical University, Simcere Pharmaceutical Co., Ltd |
| NCT03804476 | Phase 1 | Jun 26, 2018 | Aeromics, Inc., Covance |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aeromics, Inc. | For profit | 1 | 1 | 1 | 2018 |
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Covance | For profit | 1 | 0 | 1 | 2018 |
| Simcere Pharmaceutical Co., Ltd | For profit | 1 | 1 | 1 | 2021 |
4 organizations
Page 1 / 1